Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 11, 2002

View Archived Issues

Microscience advances oral typhoid vaccine into U.S. clinical trials

BioMS acquires new platform technology for hematopoietic cell mobilization

Novel small-molecule leads targeting the V2 vasopressin receptor

New data on nesiritide discussed at 2002 HFSA meeting

OSI-211 enters phase II trials in ovarian and small cell lung cancers

Polydex updates progress of Ushercell

Beneficial effects on memory reported for selective cannabinoid antagonist

BioFocus and Axxima form drug discovery partnership

Celera Genomics purchases rights to preclinical asthma compounds from Bayer

Pozen submits MT-100 MAA in U.K.

Celltech patent describes novel agents for TNF-alpha-mediated disorders

Novel tryptase inhibitors covered by Boehringer Ingelheim patent

New MMP-2 and/or MMP-13 inhibitors identified at Pharmacia

Protein kinase inhibitors described by Pharmacia as useful for cancer and other disorders

4SC and Schering AG form research collaboration

Novel antibacterial thiazolidinediones in GSK development pipeline

Multiple-dose OxyTrex and MorViva studies completed

U. of Kentucky researchers present novel camptothecin prodrugs

Phosphonate nucleotide and its oral prodrug with potent, selective anti-HBV activity

Dutasteride approved for launch as first dual-acting 5alpha-reductase inhibitor for BPH

Resovist cleared for marketing in Japan for early detection of liver tumors

Angiomax receives clearance in Canada

Broad-spectrum antiepileptic effects demonstrated for AMP-397A

Mechanism of action of plant-derived antiepileptic agent discussed by Mexican group in Madrid

Additional reduction in LDL cholesterol levels with coadministration of ezetimibe and simvastatin

The proteasome inhibitor PS-519 is safe and well tolerated in healthy volunteers

Potential use of leflunomide in psoriasis and psoriatic arthritis

Pipeline on the Move - Neurologic drugs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...